Immunocore
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunocore and other ETFs, options, and stocks.About IMCR
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom.
CEOBahija Jallal
CEOBahija Jallal
Employees493
Employees493
HeadquartersAbingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded2021
Founded2021
Employees493
Employees493
IMCR Key Statistics
Market cap1.75B
Market cap1.75B
Price-Earnings ratio-79.79
Price-Earnings ratio-79.79
Dividend yield—
Dividend yield—
Average volume294.03K
Average volume294.03K
High today$35.28
High today$35.28
Low today$34.45
Low today$34.45
Open price$35.28
Open price$35.28
Volume177.42K
Volume177.42K
52 Week high$41.54
52 Week high$41.54
52 Week low$23.15
52 Week low$23.15
Analyst ratings
78%
of 18 ratingsBuy
77.8%
Hold
16.7%
Sell
5.6%